Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Gov't & Regulatory

State FDA (SFDA), Ministry of Science and Technology (MOST), Minsitry of Health (MOH) and other China government agency policies and regulations and how they impact the industry...

China Changes Policy: US Auditors Can Examine US-Listed China Companies

China and US May Solve De-Listing Problem

I-Mab Expects Resolution of China-US Auditor Conflict without De-Listings

Three China-Based Biopharmas Receive US De-listing Notices

Innovent/Lilly PD-1 Rejected by US FDA Panel; Lilly Says Price 40% Below Competition

ChinaBio Event
Beijing and Digital
September 13-16, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022